4,6-Diphenyl-1-[(E)-(phenylmethylidene)amino]-1,2-dihydropyridin-2-one, 1g

Oxion Inverso OX.2053-PL with LWD Plan 10x/20x/40x objectives and XY cross table

(3S,6R)-1-((benzyloxy)carbonyl)-6-methylpiperidine-3-carboxylic acid, 97%, 250mg

4-amino-N-(6-chloropyridazin-3-yl)benzenesulfonamide, 95+%, 1g

2-Amino-6-fluorobenzyl amine, 98.0%, 5g

4-METHYL-5-NITRO-1H-INDAZOLE, 95%, 1g

N,N,N-Trimethylbutan-1-aminium chloride, 95.0%, 500g

Methyl 2-Bromo-4,5-difluorobenzoate, 97.0%, 10g

2-(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)acetic acid, 95.0%, 1g

3-(Pyrimidin-5-yl)propiolic acid, 95%, 500mg

Fumaraldehyde Bis(dimethyl Acetal)>90.0%(GC)5g

5-Chloronicotinaldehyde, 98.0%, 250mg

Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carboxylate, 95.0%, 100mg